Companies: 10,795·Total market cap: $144.5T
Anixa Biosciences, Inc.

Anixa Biosciences, Inc.

ANIXNASDAQHealthcare● Active
$2.46
$-0.02(-0.81%)
Market Cap$82478531
P/E Ratio
52W High$5.46
52W Low$2.44
Overview

Anixa Biosciences, Inc. (ANIX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ANIX · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.31anix eps ttm · anix earnings per shareEarnings history
PE Ratio (TTM)anix pe ratio ttm · anix price to earningsPE Ratio deep dive
Revenue (TTM)0.00anix revenue ttm · anix annual revenueFull revenue history
Dividend YieldNo Dividenddoes anix pay dividends · anix dividend yieldDividend history
Shares Outstanding32.5Manix shares outstanding · anix floatShares outstanding history
Next EarningsJun 10, 2026Est.anix earnings date · anix next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
anixa biosciences, inc. revenue · anix revenue 2025
FY 2025Net Income-$10.9M▲ +12.96% YoY
202320242025
anixa biosciences, inc. net income · anix profit 2025
FY 2025EPS$-0.34▲ +12.82% YoY
202320242025
anix eps · anixa biosciences, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$10.3MEPS: $-0.31View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy6 analystsis anix a buy · anix analyst rating
Strong Buy
0
Buy
6
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$3.50Low
$2.46Current
$5.83Avg Target136.99% upside
$10.00High
anix price target · anix 12 month forecast

Total: 6 · Buy rate: 100.0%

The ANIX analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $5.83, representing +136.99% upside from the current price of $2.46.

Stock Performance

Full History
1D-0.81%
1W-3.91%
1M-18.00%
3M-13.68%
YTD-21.15%
1Y-27.65%
5Y-42.92%

About Anixa Biosciences, Inc.

CEOAmit Kumar
IPO DateOct 7, 1983
Employees5
CountryUS
Websiteanixa.com

Anixa Biosciences, Inc. (ANIX) is a biotechnology company dedicated to pioneering therapies and vaccines. Its core mission revolves around addressing critical, unmet medical needs, particularly within…

what is anixa biosciences, inc. · anix stock overview · anixa biosciences, inc. company profile · who is anixa biosciences, inc. ceo · anix NASDAQ · anixa biosciences, inc. headquarters · anixa biosciences, inc. business segments

About Stock Overview & Key Data

Anixa Biosciences, Inc. (ANIX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 7, 1983. As of the latest trading session, ANIX stock price is $2.46, with a market capitalization of $82.5M. The stock has returned -27.65% over the past 12 months and -21.15% year-to-date.

According to 6 Wall Street analysts, the consensus rating for Anixa Biosciences, Inc. stock is Buy, with an average 12-month price target of $5.83. In fiscal year 2025, Anixa Biosciences, Inc. reported revenue of — and net income of -$10.9M. For detailed data — including Anixa Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Anixa Biosciences, Inc. (ANIX) stock price is $2.46. The stock is traded on NASDAQ under the ticker symbol ANIX. The 52-week range is $2.44 – $5.46.

ANIX stock priceANIX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice